Why the study?
VDD ICD systems provide atrial sensing via a single lead, but their arrhythmia detection efficacy compared with conventional single- and dual-chamber defibrillators required evaluation.
Does an atrioventricular defibrillator system with a floating atrial dipole (VDD ICD) improve the detection of new-onset atrial arrhythmias compared to conventional single- and dual-chamber defibrillators in patients undergoing ICD implantation?
Does an atrioventricular defibrillator system with a floating atrial dipole (VDD ICD) improve the detection of new-onset atrial arrhythmias compared to conventional single- and dual-chamber defibrillators in patients undergoing ICD implantation?
Answers are grounded in this paper and cite their sources.
VDD ICDs offer superior atrial arrhythmia detection compared to VVI systems and perform similarly to DDD systems, without increasing inappropriate shocks.
Background: An atrioventricular defibrillator system with a floating atrial dipole (VDD ICD) can provide atrial sensing by a single lead. Our aim was to compare the arrhythmia detection efficacy of VDD ICDs with conventional single- (VVI) and dual-chamber (DDD) defibrillators. Methods: Data from consecutive patients undergoing ICD implantation were retrospectively analyzed. The primary endpoint was the incidence of device-detected, new-onset atrial arrhythmias, while secondary endpoints were sensing parameters, complication rates, incidence of appropriate/inappropriate ICD therapy, arrhythmic/heart failure-related hospitalizations, and all-cause mortality. Results: A total of 256 patients (mean age 64 ± 12 years, male 75%, primary prophylaxis 28%, mean follow-up 3.7 ± 2.4 years) were included (VVI: 93, VDD: 94, DDD: 69). Atrial arrhythmia episodes were detected more frequently by VDD systems compared to VVI ICDs (aHR 7.087; 95% CI 2.371–21.183; p < 0.001), and at a rate similar to that of DDD ICDs (aHR 1.781; 95% CI 0.737–4.301; p = 0.200). The rate of inappropriate shocks was not different among the three ICD systems. Conclusion: VDD devices revealed an advantage in atrial arrhythmia detection compared to VVI ICDs and were non-inferior to DDD systems. Their main indication may be closer monitoring in high-risk patients with atrial arrhythmias to help therapy optimization and not the improvement of tachycardia discrimination.
No takes yet. Share an insight, caveat, or question.
Gausz et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: